SUBPART C—Labeling (§341.70 to §341.90)
- 341.70—Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product).
- 341.72—Labeling of antihistamine drug products.
- 341.74—Labeling of antitussive drug products.
- 341.76—Labeling of bronchodilator drug products.
- 341.78—Labeling of expectorant drug products.
- 341.80—Labeling of nasal decongestant drug products.
- 341.85—Labeling of permitted combinations of active ingredients.
- 341.90—Professional labeling.